Lawlis V Bryan insider trades
Lawlis V Bryan has filed 13 Form 4s with the SEC that we hold, for Geron Corp (GERN) (Director), Biomarin Pharmaceutical INC (BMRN) (Director) and Spyre Therapeutics, Inc. (AGLE) (Director). Across all of them we count 1 purchase worth $15.7K and 5 sales worth $1.8M reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a sale of 8,500 shares of Biomarin Pharmaceutical INC worth $825.3K, dated 2023-04-03. The first filing on our record is dated 2022-01-19 and the latest 2025-05-22.
Geron Corp (GERN)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2023-05-11 | S, sale reported on Form 4 | 35,000 | $105.0K | 2023-05-11 |
| 2024-05-15 | S, sale reported on Form 4 | 35,000 | $131.2K | 2024-05-17 |
| 2025-05-09 | P, purchase reported on Form 4 | 13,300 | $15.7K | 2025-05-13 |
Biomarin Pharmaceutical INC (BMRN)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2022-01-14 | S, sale reported on Form 4 | 4,250 | $372.3K | 2022-01-19 |
| 2022-04-14 | S, sale reported on Form 4 | 4,250 | $355.6K | 2022-04-18 |
| 2023-04-03 | S, sale reported on Form 4 | 8,500 | $825.3K | 2023-04-04 |
Spyre Therapeutics, Inc. (AGLE)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1247681) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms